153 related articles for article (PubMed ID: 32850404)
1. Comparison of Gemcitabine Plus Cisplatin vs. Docetaxel Plus Fluorouracil Plus Cisplatin Palliative Chemotherapy for Metastatic Nasopharyngeal Carcinoma.
Sun XS; Wang XH; Liu SL; Luo DH; Sun R; Liu LT; Guo SS; Chen QY; Tang LQ; Mai HQ
Front Oncol; 2020; 10():1295. PubMed ID: 32850404
[No Abstract] [Full Text] [Related]
2. Gemcitabine combined with cisplatin vs. taxane, cisplatin, and fluorouracil in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective case-control study.
Huang YM; Qiao SQ; Lu L; Chen WP; Li SL; Qi CH
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7655-7663. PubMed ID: 32744691
[TBL] [Abstract][Full Text] [Related]
3. Treatment and Survival Outcomes Associated With Platinum Plus Low-Dose, Long-term Fluorouracil for Metastatic Nasopharyngeal Carcinoma.
Zheng SH; Liu SR; Wang HB; Wei YH; Li H; Wang GN; Huang ZL; Ding SR; Chen C; Tao YL; Li XH; Glorieux C; Huang P; Wu YF; Xia YF
JAMA Netw Open; 2021 Dec; 4(12):e2138444. PubMed ID: 34902036
[TBL] [Abstract][Full Text] [Related]
4. Induction chemotherapy regimen of docetaxel plus cisplatin versus docetaxel, cisplatin plus fluorouracil followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: Preliminary results of an open-label, noninferiority, multicentre, randomised, controlled phase 3 trial.
Wang Y; Wang C; He S; Bai L; Kong F; Wang S; Cui L; Qin Q; Yang Y; Xiao W; Zhu M; Zhang Z; Lai Y; Bao W; Peng Z; Chen Y
EClinicalMedicine; 2022 Nov; 53():101625. PubMed ID: 36060517
[TBL] [Abstract][Full Text] [Related]
5. Effect of induction chemotherapy with cisplatin, fluorouracil, with or without taxane on locoregionally advanced nasopharyngeal carcinoma: a retrospective, propensity score-matched analysis.
Liu GY; Lv X; Wu YS; Mao MJ; Ye YF; Yu YH; Liang H; Yang J; Ke LR; Qiu WZ; Huang XJ; Li WZ; Guo X; Xiang YQ; Xia WX
Cancer Commun (Lond); 2018 May; 38(1):21. PubMed ID: 29764487
[TBL] [Abstract][Full Text] [Related]
6. Real-World Cost-Effectiveness Analysis of Gemcitabine and Cisplatin Compared to Docetaxel and Cisplatin Plus Fluorouracil Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma.
Yang J; Han J; He J; Duan B; Gou Q; Ai P; Liu L; Li Y; Ren K; Wang F; Yao M; Chen N
Front Oncol; 2020; 10():594756. PubMed ID: 33425747
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin.
Zeng Z; Yan RN; Tu L; Wang YY; Chen PR; Luo F; Liu L
Sci Rep; 2018 Oct; 8(1):15581. PubMed ID: 30348970
[TBL] [Abstract][Full Text] [Related]
8. Comparison of five cisplatin-based regimens frequently used as the first-line protocols in metastatic nasopharyngeal carcinoma.
Jin Y; Shi YX; Cai XY; Xia XY; Cai YC; Cao Y; Zhang WD; Hu WH; Jiang WQ
J Cancer Res Clin Oncol; 2012 Oct; 138(10):1717-25. PubMed ID: 22684794
[TBL] [Abstract][Full Text] [Related]
9. Clinical value of nedaplatin-based chemotherapy combined with radiotherapy for locoregional advanced nasopharyngeal carcinoma: a retrospective, propensity score-matched analysis.
Zhan ZJ; Tao HY; Qiu WZ; Liu ZY; Zhang RX; Liao K; Li G; Yuan YW; Yuan TZ; Zheng RH
J Cancer; 2020; 11(23):6782-6789. PubMed ID: 33123269
[No Abstract] [Full Text] [Related]
10. Effects of induction docetaxel, platinum, and fluorouracil chemotherapy in patients with stage III or IVA/B nasopharyngeal cancer treated with concurrent chemoradiation therapy: Final results of 2 parallel phase 2 clinical trials.
Kong L; Zhang Y; Hu C; Guo Y; Lu JJ
Cancer; 2017 Jun; 123(12):2258-2267. PubMed ID: 28192641
[TBL] [Abstract][Full Text] [Related]
11. Induction chemotherapy plus IMRT alone versus induction chemotherapy plus IMRT-based concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study.
Wei Z; Zhang Z; Luo J; Li N; Peng X
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1857-1864. PubMed ID: 31062162
[TBL] [Abstract][Full Text] [Related]
12. Tumor response to neoadjuvant chemotherapy predicts long-term survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma: A secondary analysis of a randomized phase 3 clinical trial.
Peng H; Chen L; Li WF; Guo R; Mao YP; Zhang Y; Guo Y; Sun Y; Ma J
Cancer; 2017 May; 123(9):1643-1652. PubMed ID: 28001301
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Toxicity of Three Induction Chemotherapy Regimens in Locoregionally Advanced Nasopharyngeal Carcinoma: Outcomes of 10-Year Follow-Up.
Peng H; Chen B; He S; Tian L; Huang Y
Front Oncol; 2021; 11():765378. PubMed ID: 34722320
[TBL] [Abstract][Full Text] [Related]
14. Addition of 5-fluorouracil to first-line induction chemotherapy with docetaxel and cisplatin before concurrent chemoradiotherapy does not improve survival in locoregionally advanced nasopharyngeal carcinoma.
Fangzheng W; Chuner J; Lei W; Fengqin Y; Zhimin Y; Quanquan S; Tongxin L; Min X; Peng W; Bin L; Aizawa R; Sakamoto M; Zhenfu F
Oncotarget; 2017 Oct; 8(53):91150-91161. PubMed ID: 29207632
[TBL] [Abstract][Full Text] [Related]
15. International randomized phase 2 study on the addition of docetaxel to the combination of cisplatin and 5-fluorouracil in the induction treatment for nasopharyngeal carcinoma in children and adolescents.
Casanova M; Özyar E; Patte C; Orbach D; Ferrari A; Veyrat-Follet C; Errihani H; Pan J; Zhang L; Shen L; Grzegorzewski KJ; Varan A
Cancer Chemother Pharmacol; 2016 Feb; 77(2):289-98. PubMed ID: 26666649
[TBL] [Abstract][Full Text] [Related]
16. Palliative chemotherapy with or without anti-EGFR therapy for de novo metastatic nasopharyngeal carcinoma: a propensity score-matching study.
Sun XS; Liang YJ; Li XY; Liu SL; Chen QY; Tang LQ; Mai HQ
Drug Des Devel Ther; 2019; 13():3207-3216. PubMed ID: 31686783
[TBL] [Abstract][Full Text] [Related]
17. Addition of 5-fluorouracil to docetaxel/cisplatin does not improve survival in locoregionally advanced nasopharyngeal carcinoma.
Fangzheng W; Chuner J; Quanquan S; Zhimin Y; Tongxin L; Jiping L; Sakamoto M; Peng W; Kaiyuan S; Weifeng Q; Zhenfu F; Yangming J
Oncotarget; 2017 Dec; 8(70):115469-115479. PubMed ID: 29383174
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Response to Different Induction Chemotherapy Regimens in Locally Advanced Nasopharyngeal Carcinoma.
Lian CL; Zhou R; Zhou Y; Zhou P; Wu SG
Drug Des Devel Ther; 2023; 17():551-562. PubMed ID: 36855516
[TBL] [Abstract][Full Text] [Related]
19. Carboplatin/5-fluorouracil as an alternative to cisplatin/5- fluorouracil for metastatic and recurrent head and neck squamous cell carcinoma and nasopharyngeal carcinoma.
Kua VF; Ismail F; Chee Ee Phua V; Aslan NM
Asian Pac J Cancer Prev; 2013; 14(2):1121-6. PubMed ID: 23621198
[TBL] [Abstract][Full Text] [Related]
20. Liposomal paclitaxel versus docetaxel in induction chemotherapy using Taxanes, cisplatin and 5-fluorouracil for locally advanced nasopharyngeal carcinoma.
Liu SL; Sun XS; Li XY; Chen QY; Lin HX; Wen YF; Guo SS; Liu LT; Xie HJ; Tang QN; Liang YJ; Yan JJ; Lin C; Yang ZC; Tang LQ; Guo L; Mai HQ
BMC Cancer; 2018 Dec; 18(1):1279. PubMed ID: 30572856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
